Á¦71Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸ : 2019-04-17±³À°ÀÏÀÚ : 2019-04-17
±³À°Àå¼Ò : ÀüÁÖ ±×·£µåÈú½ºÅÏÈ£ÅÚ ±×·¹À̽ºÈ¦ ¿Ü 3°³·ë
±³À°ÁÖÁ¦ :
Á¦71Â÷ ´ëÇÑÇǺΰúÇÐȸ Ãá°èÇмú´ëȸÁÖÃÖ±â°ü : ´ëÇÑÇǺΰúÇÐȸ
´ã´çÀÚ : ±èÀ¯Âù
¿¬¶ôó : 02-3473-0284
À̸ÞÀÏ :
kda@derma.or.kr ±³À°Á¾·ù : ÇǺΰú
Âü¼®¿¹»óÀοø : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
Àü¶óºÏµµ±³À°½Ã°£ : 21 ½Ã°£ 8ºÐ
¼¼ºÎ¼ö°·á : 500,000¿ø
ºñ°í Á¤È¸¿ø »çÀü70,000/ÇöÀå80,000, ÁØȸ¿ø »çÀü30,000/ÇöÀå40,000, ¸¸65¼¼ ÀÌ»ó ¸éÁ¦, ºñȸ¿ø 50,0000
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 04-17 ±×·¹À̽º 13:35~13:40 Introduction: Memorial lecture Chair()
±³À°½Ã°£ 04-17 ±×·¹À̽º 13:40~13:55 Epigenetic regulation in skin aging À̵¿ÈÆ(¼¿ïÀÇ´ë)
Åä·Ð 04-17 ±×·¹À̽º 13:55~14:00 Q&A ()
±âŸ 04-17 ±×·¹À̽º 13:15~13:20 Introduction Chair()
±³À°½Ã°£ 04-17 ±×·¹À̽º 13:20~13:35 Robotic hair transplantation °±¤¿µ(¸ð·¡³»ÇǺΰú)
±âŸ 04-17 ±×·¹À̽º 14:00~14:05 Introduction Chair()
±³À°½Ã°£ 04-17 ±×·¹À̽º 14:05~14:50 Rosacea: our inquiry epidemiology to microbiome Sewon Kang(Department of Dermatology, Johns Hopkins School of Medicine, USA)
Åä·Ð 04-17 ±×·¹À̽º 14:50~15:00 Q&A ()
±âŸ 04-17 ±×·¹À̽º 15:30~15:35 Introduction Chair()
±³À°½Ã°£ 04-17 ±×·¹À̽º 15:35~16:20 Photodynamic therapy for MRSA and pseudomonas-infected skin ulcer Daisuke Tsuruta(Department of Dermatology, Osaka City University, Japan)
Åä·Ð 04-17 ±×·¹À̽º 16:20~16:30 Q&A ()
±âŸ 04-17 ±×·¹À̽º 16:30~16:35 Introduction Chair()
±³À°½Ã°£ 04-17 ±×·¹À̽º 16:35~17:20 Immunotherapy for melanoma: Present and future Xiaowei Xu(Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, USA)
Åä·Ð 04-17 ±×·¹À̽º 17:20~17:30 Q&A ()
±âŸ 04-17 µ¥ÀÌÁö½º 15:30~15:33 Overview ±è¼öÂù(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 15:33~15:52 Ichthyoses ±è¼öÂù(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 15:52~16:11 Updated classification and therapeutic challenges of epidermolysis bullosa ÀÌ»óÀº(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 16:11~16:30 Genetic role in skin cancer development ¹ÚÁöÇý(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 16:30~16:49 Human genome and genomic testing in clinical practice À¯ÇÑ¿í(¼¿ï¾Æ»êº´¿ø ÀÇÇÐÀ¯ÀüÇм¾ÅÍ)
Åä·Ð 04-17 µ¥ÀÌÁö½º 16:49~17:00 Q&A ()
±³À°½Ã°£ 04-17 ±×·¹À̽º 09:30~09:54 What''s new in dermatology drugs ÀÌ°©¼®(Áß¾ÓÀÇ´ë)
Åä·Ð 04-17 ±×·¹À̽º 09:54~10:00 Q&A ()
±³À°½Ã°£ 04-17 ±×·¹À̽º 10:00~10:20 Update on publication ethics Çѵ¿¼ö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-17 ±×·¹À̽º 10:20~10:40 Conflict of interest ±è¼ö¿µ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04-17 ±×·¹À̽º 10:40~11:00 Personal data protection (publication consent) ÀÌÀº¼Ò(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04-17 ±×·¹À̽º 11:00~11:20 Reporting guidelines ³ëÁÖ¿µ(°¡ÃµÀÇ´ë)
Åä·Ð 04-17 ±×·¹À̽º 11:20~11:30 Q&A ()
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 17:30~17:52 How to claim insurance on dermatologic field Ȳö(´ëÀü¿À¶óŬÇǺΰú)
Åä·Ð 04-17 ±×·£µåº§¶ó 17:52~18:00 Q&A ()
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 18:00~18:22 How to treat onychomycosis using pinpoint laser without oral drug Ȳö(´ëÀü¿À¶óŬÇǺΰú)
Åä·Ð 04-17 ±×·£µåº§¶ó 18:22~18:30 Q&A ()
±âŸ 04-17 µ¥ÀÌÁö½º 14:00~14:03 Introduction Chair()
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 14:03~14:53 Success ÀλóÇÐ ÁÖ¼±Èñ(¿ø±¤µðÁöÅдëÇб³ ¾ó±¼°æ¿µÇаúÀå)
Åä·Ð 04-17 µ¥ÀÌÁö½º 14:53~15:00 Q&A ()
±âŸ 04-17 ±×·£µåº§¶ó 15:30~15:33 Introduction Chair()
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 15:33~16:23 ÇÁ·¹Á¨Å×ÀÌ¼Ç Æ®·»µå¿Í ÃֽŠÆÄ¿öÆ÷ÀÎÆ® È°¿ë¹ý À̱¤Èñ(´õÇÇóÇÇƼ ´ëÇ¥)
Åä·Ð 04-17 ±×·£µåº§¶ó 16:23~16:30 Q&A ()
±âŸ 04-17 ±×·£µåº§¶ó 16:30~16:33 Introduction Chair()
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 16:33~17:23 ¸¶À½À» ¿òÁ÷ÀÌ´Â ¸»°ú ±Û °¿ø±¹(ÀüºÏ´ë Ãʺù±³¼ö)
Åä·Ð 04-17 ±×·£µåº§¶ó 17:23~17:30 Q&A ()
±³À°½Ã°£ 04-17 ±×·¹À̽º 17:30~18:17 Dermatoses by Mite and Tick Á¶¹é±â(°¡Å縯ÀÇ´ë)
Åä·Ð 04-17 ±×·¹À̽º 18:17~18:30 Q&A ()
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 09:30~09:40 Á¶Á÷°Ë»ç, ¸é¿ªÇü±¤°Ë»ç ¹ÚÁؼö(´ë±¸°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 09:40~09:50 Áø±Õ ÀÌÁöÇö(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 09:50~10:00 ±¤°Ë»ç ±èÁ¤¼ö(ÇѾçÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 10:00~10:10 øÆ÷°Ë»ç ÀÌ°¡¿µ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 10:10~10:20 ¾Ë·¹¸£±â °íÇöâ(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 10:20~10:30 ´õ¸ð½ºÄÚÇÇ ¹®Á¦È£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 10:30~10:42 ½ºÅ×·ÎÀÌµå ±è¸í½Å(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 10:42~10:54 Ç×Áø±Õ/Ç×»ý ¹ÚÁø(ÀüºÏÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 10:54~11:06 ¸é¿ª¾ïÁ¦Á¦ Á¤º¸¿µ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 11:06~11:18 ·¹Æ¼³ëÀ̵å Àå¿ëÇö(°æºÏÀÇ´ë)
±³À°½Ã°£ 04-17 µ¥ÀÌÁö½º 11:18~11:30 Ç×È÷½ºÅ¸¹ÎÁ¦ ¿À»óÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 09:30~09:45 Laser basics & tissue interaction ÃÖ¿µÁØ(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 09:45~10:00 Safety related regulation À¯ÈÁ¤(°í·ÁÀÇ´ë)
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 10:00~10:15 Practical way to protect skin, eye and airway during laser surgery ±èÇý¼º(°¡Å縯ÀÇ´ë)
Åä·Ð 04-17 ±×·£µåº§¶ó 10:15~10:30 Q&A ()
±³À°½Ã°£ 04-17 ±×·¹À̽º 11:30~12:15 Recent update on sCHE and Alitretinoin Alexandra Marta(GSK)
Åä·Ð 04-17 ±×·¹À̽º 12:15~12:20 Q&A ()
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 10:30~11:15 Complete clearance, new treatment goal with Ixekizumab Prof. Yayoi Tada(Jichi medical University)
Åä·Ð 04-17 ±×·£µåº§¶ó 11:15~11:30 Q&A ()
±³À°½Ã°£ 04-17 ±×·£µåº§¶ó 14:00~14:45 Korean guideline for the treatment of onychomycosis and newer topical agent ¹ÚÁø(ÀüºÏÀÇ´ë)
Åä·Ð 04-17 ±×·£µåº§¶ó 14:45~15:00 Q&A ()
±âŸ 04-17 ¼¼ÀÎÆ® 14:00~14:05 Overview chair()
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 14:05~14:20 The associated skin diseases and comorbid allergic diseases ³ëÁÖ¿µ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 14:20~14:35 The psychosocial co-morbidities ½Å¹Î°æ(°æÈñÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 14:35~14:50 The systemic co-morbidities À̾ç¿ø(°Ç±¹ÀÇ´ë)
Åä·Ð 04-17 ¼¼ÀÎÆ® 14:50~15:00 Q&A ()
±âŸ 04-17 ¼¼ÀÎÆ® 15:30~15:35 Overview chair()
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 15:35~15:47 Upstream regulation: IL-23 ±èµ¿Çö(Â÷ÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 15:47~15:58 Downstream regulation: IL-17 ½ÅºÀ¼®(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 15:58~16:09 Resident memory T cell in psoriasis ³ªÁ¤ÀÓ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 16:09~16:20 Skin & intestinal microbiomes in psoriasis Á¤±âÇå(°æÈñÀÇ´ë)
Åä·Ð 04-17 ¼¼ÀÎÆ® 16:20~16:30 Q&A ()
±âŸ 04-17 ¼¼ÀÎÆ® 16:30~16:35 Overview ³ëÁÖ¿µ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 16:35~16:50 Pruritus: pathogenesis ±èÇý¿ø(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 16:50~17:05 Management: conventional - antihistamines Áֹμ÷(Áß¾Óº¸Èƺ´¿ø)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 17:05~17:20 Management: new treatment paradigm ÀÌÁöÇö(°¡Å縯ÀÇ´ë)
Åä·Ð 04-17 ¼¼ÀÎÆ® 17:20~17:30 Q&A ()
±âŸ 04-17 ¼¼ÀÎÆ® 17:30~17:35 Overview chair()
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 17:35~17:50 Underlying mechanism of wrinkles as a major feature of photoaging Á¤ÁøÈ£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 17:50~18:05 Underlying mechanism of dyspigmentation as another bothersome problem of photoaging °Èñ¿µ(¾ÆÁÖÀÇ´ë)
±³À°½Ã°£ 04-17 ¼¼ÀÎÆ® 18:05~18:20 Emerging treatment and promising treatment targets for skin photoaging Ã̶ֹó(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 04-17 ¼¼ÀÎÆ® 18:20~18:30 Q&A ()